By the end of this program, the viewer should be able to:

  • Discuss the main role of positron emission tomography/computed tomography (PET/CT) imaging for breast cancer patients. 
  • Discuss the advantages PET imaging offers over conventional imaging. 
  • Discuss the limitation of fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging in general and in breast cancer.


There are no prerequisites for this course.

Target Audience

The target audience is breast imagers. Other technologists and medical personnel may also benefit from viewing this program.